Literature DB >> 22166983

B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.

Vassilia-Ismini Alexaki1, Vassiliki Pelekanou, George Notas, Maria Venihaki, Marilena Kampa, Valérie Dessirier, Sanaa Sabour-Alaoui, Efstathios N Stathopoulos, Andreas Tsapis, Elias Castanas.   

Abstract

TNFα is known to be expressed in human skin, regulating immune-related responses. Here we report that human normal skin keratinocytes express the members of the TNF superfamily members A proliferation-inducing ligand (APRIL; TNFSF13), B cell-activating factor (BAFF; TNFSF13B), and their receptors, B cell maturation antigen (BCMA; TNFRSF17) and transmembrane activator, calcium-modulator, and cyclophilin ligand interactor (TACI; TNFRSF13B), in a distinct spatial pattern. Our data show a differential expression of these molecules within epidermal layers and skin appendages, whereas the BAFF-specific receptor BAFFR (TNFRSF13C) is absent. Importantly, APRIL and BCMA but not BAFF or TACI are up-regulated in inflammatory skin lesions of psoriasis and squamous cell carcinomas. To explore the functional significance of this system in the skin, we assayed these receptors and ligands in cultured primary keratinocytes and HaCaT cells. We show that both cell types express BAFF, APRIL, BCMA, and TACI. Furthermore, APRIL and/or BAFF trigger nuclear factor-κB activation and IL-6 and granulocyte macrophage colony-stimulating factor (GM-CSF) expression through functional BCMA receptors, an activation inhibited by anti-BCMA short hairpin RNA. However, BAFF and/or APRIL do not induce IL-8 or TNFα production. Our data advance BCMA as an inflammation-related TNFSFR member in keratinocytes, of potential importance in the management of inflammatory skin conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22166983     DOI: 10.1210/en.2011-1504

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Regulatory roles of the tumor necrosis factor receptor BCMA.

Authors:  Christine M Coquery; Loren D Erickson
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

2.  Distinct binding mode of BAFF antagonist antibodies belimumab and tabalumab, analyzed by computer simulation.

Authors:  Yaxin Jiang; Jian Sun; Jing Wei
Journal:  J Mol Model       Date:  2022-09-05       Impact factor: 2.172

3.  APRIL expression is upregulated in atopic dermatitis skin lesions and at sites of antigen driven allergic skin inflammation in mice.

Authors:  Juan Manuel Leyva-Castillo; Haifa H Jabara; Joerg Wenzel; Alex McGurk; Daniel Wong; Thomas Bieber; Raif S Geha
Journal:  Clin Immunol       Date:  2020-08-08       Impact factor: 3.969

4.  Expression of TNF-α, APRIL and BCMA in Behcet's disease.

Authors:  Olfat G Shaker; Shereen O Tawfic; Amira M El-Tawdy; Mohamed H M El-Komy; Manal El Menyawi; Ahmed A Heikal
Journal:  J Immunol Res       Date:  2014-11-05       Impact factor: 4.818

5.  Genome-wide methylation analysis reveals differentially methylated loci that are associated with an age-dependent increase in bovine fibroblast response to LPS.

Authors:  Filiz T Korkmaz; David E Kerr
Journal:  BMC Genomics       Date:  2017-05-25       Impact factor: 3.969

6.  BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness.

Authors:  Vasiliki Pelekanou; George Notas; Paraskevi Athanasouli; Konstantinos Alexakis; Fotini Kiagiadaki; Nikolaos Peroulis; Konstantina Kalyvianaki; Errika Kampouri; Hara Polioudaki; Panayiotis Theodoropoulos; Andreas Tsapis; Elias Castanas; Marilena Kampa
Journal:  Front Oncol       Date:  2018-08-07       Impact factor: 6.244

7.  The TNFSF Members APRIL and BAFF and Their Receptors TACI, BCMA, and BAFFR in Oncology, With a Special Focus in Breast Cancer.

Authors:  Marilena Kampa; George Notas; Efstathios N Stathopoulos; Andreas Tsapis; Elias Castanas
Journal:  Front Oncol       Date:  2020-06-16       Impact factor: 6.244

8.  Transcriptomic Analysis of Spleen Revealed Mechanism of Dexamethasone-Induced Immune Suppression in Chicks.

Authors:  Yujie Guo; Aru Su; Huihui Tian; Minxi Zhai; Wenting Li; Yadong Tian; Kui Li; Guirong Sun; Ruirui Jiang; Ruili Han; Fengbin Yan; Xiangtao Kang
Journal:  Genes (Basel)       Date:  2020-05-06       Impact factor: 4.096

9.  BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.

Authors:  Vassiliki Pelekanou; George Notas; Marilena Kampa; Eleftheria Tsentelierou; Efstathios N Stathopoulos; Andreas Tsapis; Elias Castanas
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

10.  Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma.

Authors:  De-Xiu Bu; Reshma Singh; Eugene E Choi; Marco Ruella; Selene Nunez-Cruz; Keith G Mansfield; Paul Bennett; Nathanial Barton; Qilong Wu; Jiquan Zhang; Yongqiang Wang; Lai Wei; Shawn Cogan; Tucker Ezell; Shree Joshi; Kellie J Latimer; Brian Granda; William R Tschantz; Regina M Young; Heather A Huet; Celeste J Richardson; Michael C Milone
Journal:  Oncotarget       Date:  2018-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.